HERA Trademark

Trademark Overview

On Wednesday, September 21, 2016, a trademark application was filed for HERA with the United States Patent and Trademark Office. The USPTO has given the HERA trademark a serial number of 79197805. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Thursday, May 16, 2019. This trademark is owned by Apogenix AG. The HERA trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Scientific services, namely, pharmaceutical research relating to tumor necrosis factor superfamily TNF-SF; scientific and technological services in the nature of pharmaceutical research relating to tumor necrosis factor superfamily TNF-SF; rental and leasing of items relating to the provision of services in the field of cancer and immunology, namely, rental of laboratory apparatus and instruments; consulting and information relating to pharmaceutical research in the field of tumor necrosis factor superfamily TNF-SF

Medical services relating to tumor necrosis factor superfamily TNF-SF; human healthcare services relating to tumor necrosis factor superfamily TNF-SF; rental and leasing of items relating to the provision of the aforementioned services, namely, rental of medical equipment; consulting and information relating to medical and human healthcare services relating to tumor necrosis factor superfamily TNF-SF
hera

General Information

Serial Number79197805
Word MarkHERA
Filing DateWednesday, September 21, 2016
Status402 - IR CANCELLED - US APPLICATION ABANDONED
Status DateThursday, May 16, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 26, 2017

Trademark Statements

Goods and ServicesScientific services, namely, pharmaceutical research relating to tumor necrosis factor superfamily TNF-SF; scientific and technological services in the nature of pharmaceutical research relating to tumor necrosis factor superfamily TNF-SF; rental and leasing of items relating to the provision of services in the field of cancer and immunology, namely, rental of laboratory apparatus and instruments; consulting and information relating to pharmaceutical research in the field of tumor necrosis factor superfamily TNF-SF
Goods and ServicesMedical services relating to tumor necrosis factor superfamily TNF-SF; human healthcare services relating to tumor necrosis factor superfamily TNF-SF; rental and leasing of items relating to the provision of the aforementioned services, namely, rental of medical equipment; consulting and information relating to medical and human healthcare services relating to tumor necrosis factor superfamily TNF-SF

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, May 16, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, May 16, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameApogenix AG
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDE
Party NameApogenix AG
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDE

Trademark Events

Event DateEvent Description
Saturday, June 15, 2019OPPOSITION TERMINATED NO. 999999
Saturday, June 15, 2019OPPOSITION SUSTAINED NO. 999999
Saturday, June 1, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, May 31, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, May 25, 2018NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, May 9, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 9, 2018NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, March 2, 2018REFUSAL PROCESSED BY IB
Tuesday, February 6, 2018OPPOSITION INSTITUTED NO. 999999
Thursday, February 1, 2018NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, January 30, 2018OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Tuesday, January 30, 2018OPPOSITION NOTICE (IB REFUSAL) CREATED
Thursday, January 25, 2018OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, December 26, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 26, 2017PUBLISHED FOR OPPOSITION
Friday, December 22, 2017NOTIFICATION PROCESSED BY IB
Wednesday, December 6, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 6, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 6, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Monday, November 20, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 20, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 20, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 20, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, October 27, 2017LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, September 29, 2017NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, August 29, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, August 29, 2017FINAL REFUSAL E-MAILED
Tuesday, August 29, 2017FINAL REFUSAL WRITTEN
Friday, August 25, 2017LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, August 15, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 15, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 8, 2017ASSIGNED TO LIE
Tuesday, July 11, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 27, 2017REFUSAL PROCESSED BY IB
Wednesday, January 11, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, January 11, 2017REFUSAL PROCESSED BY MPU
Tuesday, January 3, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, January 2, 2017NON-FINAL ACTION WRITTEN
Wednesday, December 28, 2016ASSIGNED TO EXAMINER
Tuesday, December 20, 2016APPLICATION FILING RECEIPT MAILED
Friday, December 16, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 8, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

hera relating services tumor superfamily factor necrosis rental research medical namely